Literature DB >> 9490269

Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma.

B J O'Hara1, A Paetau, M Miettinen.   

Abstract

Thirty-five chordomas and more than 100 other tumors that have to be considered in the differential diagnosis, were immunohistochemically analyzed using a panel of antibodies including those to subsets of keratins (K), HBME-1, a monoclonal antibody recognizing an unknown antigen on mesothelial cells, and neuroendocrine markers. The patterns of immunoreactivities in chordoma were compared with those in renal cell carcinoma, colorectal mucinous adenocarcinoma, pituitary adenoma, skeletal chondrosarcoma, and extraskeletal myxoid chondrosarcoma (ESMC). Chordomas were consistently positive for keratin cocktail AE1/AE3, and for the individual keratins K8 and K19, and nearly always positive for K5, but they showed negative or only sporadic reactivity for K7 and K20. The keratin K8 and K19 reactivity was retained in those chordomas showing solid sheets of epithelioid, spindle cells, or cartilaginous metaplasia, and in one of two cases showing overtly sarcomatous transformation. In comparison, keratins were never present in skeletal chondrosarcoma, although K8 and to a lesser extent K19 were seen in occasional cases of ESMC with chordoid features. HBME-1 reacted strongly with chordoma and skeletal chondrosarcoma but was almost never positive in renal or colorectal carcinoma. These carcinomas lacked K5-reactivity, in contrast to chordoma. Chordomas were also consistently positive for neuron-specific enolase and occasionally focally for synaptophysin, but never for chromogranin. In contrast, pituitary adenomas regularly expressed the full spectrum of neuroendocrine markers and differed from chordoma by having a narrower repertoire of keratins, often showing negative or focal keratin 8- or AE1/AE3 reactivity and being almost always K19-negative. These findings indicate that chordoma can be immunohistochemically separated from tumors that can resemble it. Immunohistochemistry is especially useful in the diagnosis of small biopsy specimens that offer limited material for morphological observation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490269     DOI: 10.1016/s0046-8177(98)90220-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  20 in total

Review 1.  Current therapeutic options and novel molecular markers in skull base chordomas.

Authors:  Filippo Gagliardi; Nicola Boari; Paola Riva; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

2.  Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.

Authors:  Ankur R Sangoi; Mohanpal S Dulai; Andrew H Beck; Daniel J Brat; Hannes Vogel
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

3.  Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation.

Authors:  Paul O'donnell; Roberto Tirabosco; Sonja Vujovic; William Bartlett; Timothy W R Briggs; Stephen Henderson; Chris Boshoff; Adrienne M Flanagan
Journal:  Skeletal Radiol       Date:  2006-06-30       Impact factor: 2.199

4.  Cytokeratin CK 7 and CK 20 expression in pituitary adenomas.

Authors:  Stephen W Coons; Sarah I Estrada; Ruben Gamez; William L White
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 5.  Benign notochordal lesions of the axial skeleton: a review and current appraisal.

Authors:  Michael Kyriakos
Journal:  Skeletal Radiol       Date:  2011-08-17       Impact factor: 2.199

6.  Benign notochordal cell tumor: a retrospective study of 11 cases with 13 vertebra bodies.

Authors:  Xiaomei Ma; Chunyan Xia; Dong Liu; Huimin Liu; Chenguang Wang; Hongyu Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 7.  The application of immunohistochemistry in the diagnosis of bone tumors and tumor-like lesions.

Authors:  Zhenqiang Gao; Leonard B Kahn
Journal:  Skeletal Radiol       Date:  2005-09-28       Impact factor: 2.199

8.  Extra-axial chordomas.

Authors:  S Evans; Z Khan; L Jeys; R Grimer
Journal:  Ann R Coll Surg Engl       Date:  2016-05       Impact factor: 1.891

9.  Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes.

Authors:  László Krenács; Judit Tóth-Lipták; Judit Demeter; Klára Piukovics; Zita Borbényi; Péter Gogolák; Eszter Sári; Enikő Bagdi
Journal:  Virchows Arch       Date:  2013-10-05       Impact factor: 4.064

10.  Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors.

Authors:  Cord Langner; Beate J Wegscheider; Manfred Ratschek; Luigi Schips; Richard Zigeuner
Journal:  Virchows Arch       Date:  2004-01-16       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.